References
- Jang M, Kim J, Han I, Yang W. Simultaneous determination of LSD and 2-oxo-3-hydroxy LSD in hair and urine by LC-MS/MS and its application to forensic cases. J Pharm Biomed Anal. 2015;115:138–143. doi:10.1016/j.jpba.2015.07.001
- Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol. 2014;10:45–50. doi:10.1007/s13181-013-0314-y
- Arantes LC, Júnior EF, Souza LF, Cardoso AC, Alcântara TLF, Lião LM, Machado Y, Lordeiro RA, Neto JC, Andrade AFB. 25I-NBOH: a new potent serotonin 5-HT2A receptor agonist identified in blotter paper seizures in Brazil. Forensic Toxicol. 2017;35:408–414. doi:10.1007/s11419-017-0357-x
- Krotulski AJ, Mohr ALA, Papsun DM, Logan BK. Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. Drug Test Anal. 2017;1:1–10.
- Martin R, Schürenkamp J, Gasse A, Pfeiffer H, Köhler H. Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS. Int J Legal Med. 2012;127:593–601.
- Enmanuele E, Colombo R, Martinelli V, Brondino N, Marini M, Boso M, Barale F, Politi P. Elevated urine levels of bufotenine in patients with autistic spectrum disorder and schizophrenia. Neuroendocinol Lett. 2010;31(1):101–105.